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Infection of a prosthesis on the ascending aorta is a seriouscomplication associated with a high mortality. The standardapproach to this problem includes excision and replacementor debridement and repair of infected thoracic aortic grafts. In
most cases, extra-anatomic bypass and removal of the infected vas-
cular graft are not possible and reconstruction of arterial continu-
ity may be a difficult problem. We report the successful treatment
of this life-threatening complication using a strategy in which an
infected ascending aortic prosthesis was replaced by an abdominal
aortic autograft. The technical aspects and the rationale of this
approach are presented.
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Case Presentation
The patient was a 34-year-old man with diabetes who underwent
urgent repair of a traumatic lesion of the ascending aorta conse-
quent to an automobile accident. The ascending aorta, affected by
a limited dissection, was replaced with a 24-mm Dacron graft. The
operation and the subsequent course were uneventful, with the
exception of subxiphoid pericardial decompression on postopera-
tive day 5. Six weeks after the operation, the patient was readmit-
ted with fever (40°C), chills, an abnormal white blood cell count
(32 × 109/L), an elevated erythrocyte sedimentation rate (76 mm in
the first hour), and blood cultures positive for methicillin-resistant
Staphylococcus aureus. The antibiotic regimen included van-
comycin, ofloxacin, ceftazidime, and gentamicin. Blood cultures
became negative after 4 days, but intermittent fever persisted.
Transesophageal echocardiography excluded valvular bacterial
vegetation but revealed fluid accumulation around the prosthesis.
Chest computed tomographic scan demonstrated a large perigraft
abscess; therefore, the patient was taken to the operating room for
treatment. Abdominal computed tomographic scan and duplex
scan echography were obtained before the operation to exclude
major structural abnormalities of the abdominal aorta. 
The operation was performed in two steps to avoid contamina-
tion of the abdominal incision. The abdominal aorta was exposed
through a retroperitoneal approach. Under moderate heparinization
(50 mg), the aorta was crossclamped below the renal arteries and
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above the iliac bifurcation, and the inferior mesenteric artery was
divided for subsequent reimplantation. The abdominal aorta was
then transected and harvested, dividing the lumbar arteries, whose
ostia on the aortic side were sutured with single 5-0 polypropylene
stitches. The aortic autograft was stored in sterile cold saline solu-
tion. It was free from structural abnormalities. Its diameter was 22
mm and its length was 55 mm. The abdominal aorta was replaced
by a cryopreserved abdominal aorta homograft and the inferior
mesenteric artery was reimplanted. The patient was then reposi-
tioned in a supine decubitus position and the chest was opened
through a redo sternotomy. We found a large perigraft abscess.
Purulent fluid, which cultured positively for methicillin-resistant
Staphylococcus aureus, had puddled around the aortic prosthesis
and was in direct contact with the exposed suture lines. 
After full heparinization left axillary artery and right atrial
appendage were cannulated. The patient was cooled at 25°C, the
aorta crossclamped beyond the distal anastomosis of the graft, and
retrograde blood cardioplegia administered. 
After copious irrigation with povidone-iodine solution (0.2%)
and debridement of devitalized tissue, all synthetic material was
removed. The ascending aorta was then replaced with the abdomi-
nal aorta autograft by means of 5-0 polypropylene continuous
sutures. An irrigation device allowed intermittent irrigation of the
pericardium with a solution composed of 0.03% of povidone-
iodine with 1000 mL of physiologic saline solution 3 to 5 times a
day. After each wash, the drainage tubes were clamped and the
mediastinum filled with 0.5 g of vancomycin hydrochloride dis-
solved in 100 mL of physiologic saline solution and maintained for
30 minutes. The postoperative course was uncomplicated and the
patient’s temperature returned to normal limits over the next 6
days. The culture of drainage remained negative after 9 day of irri-
gation. The intravenous antibiotic regimen was continued for 15
days. The patient was discharged on postoperative day 30, after
demonstration by computed tomographic scan of normal healing
of the abdominal aorta and no evidence of residual perigraft fluid
or inflammation in the mediastinum. At 6 months he is free of
symptoms with normal follow-up studies of the aorta. Both galli-
um 67 citrate and indium 111 labeled autologous leukocyte imag-
ing reveal no evidence of residual sepsis.
Discussion
The reported incidence of graft infections of all types after thoracic
aortic operations ranges from 0.9% to 1.9%,1 and recent series of
thoracic aortic graft infections reported an in-hospital mortality of
42%.2,3 The established principles regarding the management of an
infected vascular prosthesis include explantation of the infected
graft, extra-anatomic bypass of blood through a clean field, radical
debridement of all infected/necrotic tissues, in situ irrigation with
an antimicrobial solution, and systemic antibiotics.3 However,
extra-anatomic bypass, the cornerstone of management for infect-
ed vascular grafts, is less realistic for infected thoracic aortic grafts
because of anatomic and physiologic considerations. Instead, the
standard surgical approach to this problem has been excision and
in situ replacement of the infected prosthesis with another synthet-
ic graft or a homograft. 
Reconstruction with biomaterial has a lower infectability rate
than that of prosthetic grafts, and experimental studies have shown
that resistance to infection of fresh arterial allografts is close to that
of autologous grafts.4
Nevertheless, freshly implanted homografts are exposed to
immunologically mediated rejection, resulting in progressive
degeneration of the elastic fibers and collagen connective tissue.
Moreover, the infiltration of macrophages and Langerhans cells
causes rarification of the tissue and necrosis5 that leads to a loss of
the mechanical strength, aneurysm formation, and rupture. This
sequence is not observed in cryopreserved arterial homografts,
which undergo a limited cellular and humoral rejection.6 However,
late degeneration and disruption of cryopreserved allografts has
been documented7,8 and the risk of secondary rupture should be
considered.
The strategy adopted in this patient relies on the virulence of
the microbial agent, which imposed the choice of a substitute with
the lowest infectability potential, and on the young age of the
patient, which necessitated that we reduce as much as possible the
risk of future reoperations on the ascending aorta.
Abdominal autograft is a fresh substitute, which fulfills the req-
uisites of maximal resistance in a septic milieu and safety from the
risks of rejection and late degeneration. The use of cryopreserved
homograft in the abdominal position, although potentially at risk
for late degeneration, was preferable to a prosthetic reconstruction
in this patient. Moreover, prospective reoperations on this segment
of the aorta carry lower operative risks than do reoperations on the
thoracic aorta. 
In addition to providing a novel technique for reconstruction of
the ascending aorta, this case illustrates that control of infection is
well achieved with abdominal aortic autograft. This method, how-
ever, requires further clinical evaluation and follow up.
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